The sustained insider selling by an officer over the past three weeks is a bearish signal, especially given the absence of any insider buying. Traders should monitor for any negative catalysts or upcoming news that might explain the selling pattern.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 9 $51.63entry
- T+1 · 5mo ago +0.91%α +2.49% · $52.10
- T+5 · 5mo ago +15.26%α +12.85% · $59.51
- T+20 · 4mo ago +30.40%α +28.95% · $67.33
- T+60 · 3mo ago +8.15%α +4.34% · $55.84
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 notice of intent to sell 21,987 shares of common stock, with an approximate market value of $1.12 million. The shares to be sold were acquired through restricted stock vesting and a stock option exercise. This filing follows a series of recent insider sales by Mulroy totaling over 183,000 shares since mid-May 2026, indicating a sustained pattern of monetization.
Key Facts
- Officer Dennis Mulroy filed Form 144 to sell 21,987 shares valued at ~$1.12 million.
- Shares originate from restricted stock grants (01/03/2025, 01/06/2025) and a stock option exercise (06/08/2026).
- Mulroy has sold over 183,000 shares in a series of trades from May 15 to June 5, 2026, totaling ~$9.6 million.
- The filing is an advance notice of intent to sell; the actual sale may or may not occur.
- No prior insider buying activity was reported in the last 30 days.
Financial Impact
Proposed sale of 21,987 shares at ~$1.12 million; cumulative recent insider sales by Mulroy exceed $9.6 million.
Risk Factors
- Insider selling may indicate lack of confidence in near-term prospects.
- Continued selling could pressure the stock price if the market interprets it as a negative signal.
- The filing is only an intent to sell; the actual sale may not materialize, reducing the signal's reliability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005794 |
| Document: 0001950047-26-005794-index.html | 0001950047-26-005794 |
| Document: 0001950047-26-005794.txt | 0001950047-26-005794 |
Track record
28 reports on ANAB
10 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 18 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
- Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
- Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
- Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
- Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
- Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
- Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers